[11] Basen-Engquist, K., & Chang, M
The GLP-1 RA monitoring report describes more detailed information about the overall population of patients being prescribed these medications (including demographics, comorbidities, social drivers of health data like income and education, and more), and the proportion and characteristics of patients who filled a GLP-1 RA prescription over time using dispenses
Longer-term data from the XENDOS trial demonstrated that orlistat 120 mg (prescription strength), combined with lifestyle intervention, reduced the progression from impaired glucose tolerance to type 2 diabetes compared with lifestyle intervention alone
Some individuals may use Tirzepatide for a specific period to achieve a health milestone, like significant weight loss or reversing insulin resistance, while using that time to build sustainable lifestyle habits
All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and later versions.Written informed consent was approved by the IRB and signed by all participants before enrolment